PARIS and SAN DIEGO, Oct. 12, 2020 /PRNewswire/ — WeHealth™ Digital Medicine, Servier Group’s e-health business unit, and CureMatch®, a leader in digital health precision medicine today announced that they have received CE Mark approval for Bionov™, their professional-use clinical decision support software…. read more See full article here
Oncology is currently the largest area of clinical health expenditures for prescription drugs in the United States [1], and, based on the current pace of innovation in cancer care, anti-cancer treatment costs are only expected to increase [2]. Still, cancer remains a significant medical challenge, stubbornly resistant to conventional treatments. Further, many patients with cancer […]
CureMatch is pleased to announce our recent nomination for two innovation awards. MedTech announced that CureMatch is nominated for Best Technological Innovation: Diagnostics and Best Technological Innovation: Digital in their 2019 Insight Awards. The award ceremony will be held September 23 in Boston, Massachusetts, during the MedTech conference, hosted by AdvaMed. This valuable annual conference […]
SAN DIEGO, CA – July 22, 2019 – CureMatch is pleased to announce the hire of Yekaterina Khotskaya as vice president of clinical operations. As head of CureMatch’s clinical operations, Dr. Khotskaya will bring her experience in research, software development, project management, and molecular diagnostics to work hand in hand with clinicians to bring CureMatch’s […]